Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$521K Buy
+30,200
New +$538K ﹤0.01% 6056
2025
Q3
Sell
-30,000
Closed -$628K 10639
2025
Q2
$628K Buy
30,000
+29,600
+7,400% +$673K ﹤0.01% 5831
2025
Q1
$9.59K Sell
400
-200,000
-100% -$4.43M ﹤0.01% 8682
2024
Q4
$4.28M Sell
200,400
-299,600
-60% -$6.79M ﹤0.01% 3992
2024
Q3
$11.6M Hold
500,000
﹤0.01% 2237
2024
Q2
$9.09M Buy
+500,000
New +$9.69M ﹤0.01% 2287
2024
Q1
Sell
-1,646,400
Closed -$35.4M 9709
2023
Q4
$35.4M Sell
1,646,400
-483,600
-23% -$9.68M 0.01% 1197
2023
Q3
$42.8M Buy
+2,130,000
New +$49.3M 0.01% 958

Other funds holding KVUE

UBS Group's KVUE Position: Q1 2026 in Review

UBS Group reduced its Kenvue (KVUE) stake by 50% in Q1 2026, selling an estimated $374M and leaving 20,763,700 shares worth $358M. The position accounts for 0.05% of the portfolio, ranked #364.

UBS Group first reported a position in KVUE in Q2 2023 and has held it in 12 quarters since. The position peaked at $720M in Q4 2025. 1,013 funds tracked by Wall St. Rank hold KVUE as of Q1 2026.

  • UBS Group held 20,763,700 shares of Kenvue worth $358M as of Q1 2026.
  • UBS Group sold 20,988,272 Kenvue shares in Q1 2026, an estimated $374M.
  • Kenvue made up 0.05% of UBS Group's portfolio in Q1 2026, its #364 holding.
  • UBS Group first reported a position in Kenvue in Q2 2023 and has held it in 12 quarters since.
  • UBS Group's Kenvue position peaked at $720M in Q4 2025.
  • 1,013 funds tracked by Wall St. Rank held Kenvue as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.